MKI67 and neoplasm: As a treatment modality radiotherapy preferentially targets proliferating tumour cell populations in the M and G2 phase of the cell cycle11,57, and within growing VS tumour associated macrophages (TAM) rather than Schwann cells were previously found to account for the majority of Ki67+ proliferating cells1,3,16.